In a recent study posted to the bioRxiv* preprint server, researchers investigated the expression of complement regulatory proteins (CRPs) in coronavirus disease 2019 (COVID-19) to identify potential ...
Researchers across the planet are racing to harness one of the immune system’s front-line defenders as an early treatment for covid-19, the disease caused by the coronavirus that has killed more than ...
A new study shows that about two percent of the population develop autoantibodies against type 1 interferons, mostly later in life. This makes individuals more susceptible to viral diseases like COVID ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results